Results 191 to 200 of about 16,224 (216)

[HTLV-I antibody screening of blood donors].

Beitrage zur Infusionstherapie = Contributions to infusion therapy, 1992
Routine screening of 344,266 blood donations of approximately 200,000 donors for anti-HTLV-I was done by enzyme immuno assay (EIA). Repeatedly reactive samples were confirmed by Western Blot (WB) and radio immuno precipitation assay (RIPA). The prevalence of anti-HTLV-I in Bavarian blood donors is 0.02-0.026%. The specificity of HTLV-I-EIA is 99.95%.
G, Schwarzfischer, H, Schätzl, U, Bäcker, W, Weise, K, von der Helm, F, Deinhardt   +5 more
openaire   +1 more source

Polymyositis and HTLV‐I antibodies

Annals of Neurology, 1989
D. A. Francis, R. A. C. Hughes
openaire   +1 more source

Antibodies to HTLV-I in Sjögren's syndrome

The Lancet, 1995
Xavier Mariette, Patrick Cherot, Dominique Cazals, Claude Brocheriou, Jean-Claude Brouet, Félix Agbalika, Laurent Bélec, Marie-Claude Georges, Jacques Pillot, Alain Georges, Werner Vogetseder, L-J. Coulderc, C. Desgranges, J. Coste, I. Caubarrere, J-P. Clauvel   +15 more
openaire   +1 more source

A protective role of HTLV-1 gp46-specific neutralizing and antibody-dependent cellular cytotoxicity-inducing antibodies in progression to adult T-cell leukemia (ATL)

Frontiers in Immunology, 2022
Naoki Imaizumi, Kazuiku Ohshiro, Tanaka Yuetsu   +2 more
exaly  

[Significance of anti-HTLV-I antibody in cerebrospinal fluid in diagnosis of HTLV-I associated myelopathy (HAM)].

Rinsho byori. The Japanese journal of clinical pathology, 1992
Anti-HTLV-I antibody was measured in 69 cerebrospinal fluids (CSFs) of cases with typical HTLV-I associated myelopathy (HAM) and other disorders whose symptoms were similar to HAM in order to evaluate the diagnostic significance of anti-HTLV-I antibody in CSF.
M, Suehara, S, Izumo, I, Kumamoto, M, Osame   +3 more
openaire   +1 more source

HTLV-I/II antibodies in French blood donors

The Lancet, 1990
J, Coste, J M, Lemaire, F, Barin, A M, Courouce   +3 more
openaire   +2 more sources

Antibodies to HTLV-I p24 in African and Portuguese populations.

Cancer research, 1985
Using a radioimmunoassay to detect HTLV-I protein antibodies of molecular weight 24,000, we screened populations from Algeria (140 subjects), Tunisia (442), Mali (69), Senegal (415), Uganda (135), the Central African Republic (77), the Congo (360), and Madagascar (193). Only four subjects were positive (1 from Senegal, 1 from Uganda, 2 from the Congo).
B, Larouze, L, Schaffar-Deshayes, S, Blesonski, C, Gaudebout, J M, Afoutou, P, Couillin, M, Da Graca Porto, L, Diakhate, M L, Frelut, M, Jeddi   +9 more
openaire   +1 more source

Anti-HTLV-1/2 IgG Antibodies in the Breastmilk of Seropositive Mothers

Microorganisms, 2021
Carolina Rosadas, Jana Haddow, Aileen G Rowan   +2 more
exaly  

ANTIBODIES TO HTLV-III/LAV AMONG ABORIGINAL AMAZONIAN INDIANS IN VENEZUELA

Lancet, The, 1985
Faruk Sinangil, Fernando Merino, Stephen Dewhurst   +2 more
exaly  

Prevalence of serum and salivary antibodies to HTLV-1 in Sjögren's syndrome

Lancet, The, 1994
Ryozo Moriuchi, I Yamashita, Masakazu Kita   +2 more
exaly